A comparison between warfarin and apixaban: A patient's perspective

BACKGROUND: Novel oral anticoagulants (NOACs) were developed as alternatives to warfarin. However, the patients' preference regarding warfarin or the NOACs has not been established. Quality-of-life (QOL) surveys are a well-established method for determining the patients' preference for a t...

Descripción completa

Detalles Bibliográficos
Autores principales: Althemery, Abdullah U., Alfaifi, Abdullah A., Alturaiki, Abdulrahman, Ammari, Maha A. L., Sultana, Khizra, Lai, Leanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259398/
https://www.ncbi.nlm.nih.gov/pubmed/32489443
http://dx.doi.org/10.4103/atm.ATM_352_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259398/
https://www.ncbi.nlm.nih.gov/pubmed/32489443
http://dx.doi.org/10.4103/atm.ATM_352_19

Ejemplares similares